好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Anti-NMDA Receptor-Related Autoantibodies and Therapeutic Outcome in Acute Non-Herpetic Encephalitis Accompanied with Refractory Seizures in Young Women
Epilepsy
(-)
101
Authors/Disclosures
Hiroyuki Ishiura, MD (The University of Tokyo) No disclosure on file
Mana Higashihara, MD No disclosure on file
No disclosure on file
Tomotaka Yamamoto No disclosure on file
Jun Shimizu, MD, PhD (Tokyo University of Technology) No disclosure on file
Jun Goto, MD, PhD (International University of Health and Welfare Ichikawa Hospital) No disclosure on file
Josep O. Dalmau, MD, PhD, FAAN Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care.
No disclosure on file
Shoji Tsuji, MD, PhD (University of Tokyo) The institution of Dr. Tsuji has received research support from Novelpharma Co. Ltd..